• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

疏水型深共晶溶剂(HDES)作为脂基药物制剂的油相。

Hydrophobic deep eutectic solvent (HDES) as oil phase in lipid-based drug formulations.

机构信息

Zentiva, k.s., U Kabelovny 130 102 00, Praha 10, Czech Republic; University of Basel, Department of Pharmaceutical Sciences, Klingelbergstrasse 50 4056, Basel, Switzerland; University of Applied Sciences and Arts Northwest. Switzerland, School of Life Sciences, Institute of Pharma Technology, Hofackerstr. 30 CH- 4132, Muttenz, Switzerland.

Zentiva, k.s., U Kabelovny 130 102 00, Praha 10, Czech Republic.

出版信息

Int J Pharm. 2024 Aug 15;661:124418. doi: 10.1016/j.ijpharm.2024.124418. Epub 2024 Jul 2.

DOI:10.1016/j.ijpharm.2024.124418
PMID:38964488
Abstract

There is increasing pharmaceutical interest in deep eutectic solvents not only as a green alternative to organic solvents in drug manufacturing, but also as liquid formulation for drug delivery. The present work introduces a hydrophobic deep eutectic solvent (HDES) to the field of lipid-based formulations (LBF). Phase behavior of a mixture with 2:1 M ratio of decanoic- to dodecanoic acid was studied experimentally and described by thermodynamic modelling. Venetoclax was selected as a hydrophobic model drug and studied by atomistic molecular dynamics simulations of the mixtures. As a result, valuable molecular insights were gained into the interaction networks between the different components. Moreover, experimentally the HDES showed greatly enhanced drug solubilization compared to conventional glyceride-based vehicles, but aqueous dispersion behavior was limited. Hence surfactants were studied for their ability to improve aqueous dispersion and addition of Tween 80 resulted in lowest droplet sizes and high in vitro drug release. In conclusion, the combination of HDES with surfactant(s) provides a novel LBF with high pharmaceutical potential. However, the components must be finely balanced to keep the integrity of the solubilizing HDES, while enabling sufficient dispersion and drug release.

摘要

制药行业对深共熔溶剂的兴趣日益浓厚,不仅将其视为药物制造中有机溶剂的绿色替代品,还将其视为药物传递的液体制剂。本工作将疏水性深共熔溶剂(HDES)引入脂质基制剂(LBF)领域。实验研究了癸酸-十二酸摩尔比为 2:1 的混合物的相行为,并通过热力学模型进行了描述。选择 Venetoclax 作为疏水性模型药物,并对混合物进行了原子分子动力学模拟研究。结果,深入了解了不同成分之间的相互作用网络。此外,实验表明,与传统的甘油酯基载体相比,HDES 大大提高了药物的溶解度,但水分散行为受到限制。因此,研究了表面活性剂改善水分散的能力,添加 Tween 80 可得到最低的液滴尺寸和高体外药物释放。总之,HDES 与表面活性剂(s)的结合提供了一种具有高药物潜力的新型 LBF。然而,必须精细平衡各成分,以保持溶解 HDES 的完整性,同时实现足够的分散和药物释放。

相似文献

1
Hydrophobic deep eutectic solvent (HDES) as oil phase in lipid-based drug formulations.疏水型深共晶溶剂(HDES)作为脂基药物制剂的油相。
Int J Pharm. 2024 Aug 15;661:124418. doi: 10.1016/j.ijpharm.2024.124418. Epub 2024 Jul 2.
2
In vitro assessment of drug-free and fenofibrate-containing lipid formulations using dispersion and digestion testing gives detailed insights into the likely fate of formulations in the intestine.采用分散和消化试验对无药物和非诺贝特载脂体制剂进行体外评估,可深入了解制剂在肠道中的可能命运。
Eur J Pharm Sci. 2013 Jul 16;49(4):748-60. doi: 10.1016/j.ejps.2013.04.036. Epub 2013 May 16.
3
Complex Micellization Behavior of the Polysorbates Tween 20 and Tween 80.聚山梨酯 20 和聚山梨酯 80 的复杂胶束化行为。
Mol Pharm. 2021 Aug 2;18(8):3147-3157. doi: 10.1021/acs.molpharmaceut.1c00406. Epub 2021 Jul 12.
4
Extraction of curcuminoids and ar-turmerone from turmeric (Curcuma longa L.) using hydrophobic deep eutectic solvents (HDESs) and application as HDES-based microemulsions.用疏水性深共晶溶剂(HDES)从姜黄(Curcuma longa L.)中提取姜黄素和 ar-姜烯酮及其作为基于 HDES 的微乳液的应用。
Food Chem. 2022 Dec 1;396:133728. doi: 10.1016/j.foodchem.2022.133728. Epub 2022 Jul 16.
5
Liquid-Liquid Extraction of Furfural from Water by Hydrophobic Deep Eutectic Solvents: Improvement of Density Function Theory Modeling with Experimental Validations.疏水性低共熔溶剂从水中液液萃取糠醛:通过实验验证改进密度泛函理论建模
ACS Omega. 2020 Aug 24;5(35):22305-22313. doi: 10.1021/acsomega.0c02665. eCollection 2020 Sep 8.
6
Enabling superior drug loading in lipid-based formulations with lipophilic salts for a brick dust molecule: Exploration of lipophilic counterions and in vitro-in vivo evaluation.利用亲脂性盐使亲脂性药物在基于脂质的制剂中实现高载药量:亲脂性反离子的探索及体内外评价。
Int J Pharm. 2024 May 10;656:124108. doi: 10.1016/j.ijpharm.2024.124108. Epub 2024 Apr 9.
7
Toward Developing Discriminating Dissolution Methods for Formulations Containing Nanoparticulates in Solution: The Impact of Particle Drift and Drug Activity in Solution.针对含有纳米颗粒的制剂开发有区分力的溶出方法:颗粒漂移和溶液中药物活性的影响。
Mol Pharm. 2020 Nov 2;17(11):4125-4140. doi: 10.1021/acs.molpharmaceut.0c00599. Epub 2020 Oct 21.
8
Structure and dynamics of hydrophobic deep eutectic solvents composed from terpene-fatty acids investigated by molecular dynamics simulation.通过分子动力学模拟研究萜烯-脂肪酸组成的疏水深共晶溶剂的结构和动力学。
J Mol Graph Model. 2022 Jul;114:108180. doi: 10.1016/j.jmgm.2022.108180. Epub 2022 Mar 22.
9
Self-microemulsifying smaller molecular volume oil (Capmul MCM) using non-ionic surfactants: a delivery system for poorly water-soluble drug.使用非离子表面活性剂的自微乳化小分子体积油(Capmul MCM):一种难溶性药物的给药系统。
Drug Dev Ind Pharm. 2012 Jul;38(7):883-92. doi: 10.3109/03639045.2011.631548. Epub 2011 Nov 16.
10
Development of self emulsifying lipid formulations of BCS class II drugs with low to medium lipophilicity.低到中等亲脂性 BCS 类 II 药物自乳化脂质体制剂的开发。
Int J Pharm. 2015 Nov 10;495(1):385-392. doi: 10.1016/j.ijpharm.2015.09.009. Epub 2015 Sep 10.

引用本文的文献

1
Exploring Deep Eutectic Solvents as Pharmaceutical Excipients: Enhancing the Solubility of Ibuprofen and Mefenamic Acid.探索深共熔溶剂作为药物辅料:提高布洛芬和甲芬那酸的溶解度
Pharmaceuticals (Basel). 2024 Oct 2;17(10):1316. doi: 10.3390/ph17101316.
2
Thermally-Induced Supersaturation Approach for Optimizing Drug Loading and Biopharmaceutical Properties of Supersaturated Lipid-Based Formulations: Case Studies with Ibrutinib and Enzalutamide.热致过饱和法优化脂质体载药及生物药剂学性质:以伊布替尼和恩杂鲁胺为例
AAPS PharmSciTech. 2024 Aug 20;25(7):192. doi: 10.1208/s12249-024-02912-9.